Projects funded by the NCN
Role of apelin and chemerin in selected aspects of ovarian cancer progression using two- and three-dimensional model in vitro.
2016/21/N/NZ5/00161
Keywords:
apelin chemerin IGF1 E2 proliferation apoptosis ovarian cancer
Descriptors:
- NZ5_9: Other related subjects
- NZ4_6: Endocrinology
- NZ3_1: Cell biology
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Jagielloński, Wydział Biologii
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 11 - announced on 2016-03-15
Amount awarded: 99 996 PLN
Project start date (Y-m-d): 2017-03-21
Project end date (Y-m-d): 2019-03-20
Project duration:: 24 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Publication in academic press/journals (1)
- Articles in post-conference publications (1)
- Apelin abrogates the stimulatory effects of 17β-estradiol and insulin-like growth factor-1 on proliferation of epithelial and granulosa ovarian cancer cell lines via crosstalk between APLNR and ERα/IGF1RAuthors:Marta Hoffmann, Justyna Gogola, Anna PtakAcademic press:Molecular Biology Reports (rok: 2019, tom: 46, strony: 6325-6338), Wydawca: SpringerStatus:PublishedDOI:10.1007/s11033-019-05073-2 - link to the publication
- 17 β-estradiol reverses apelin-inducing ovarian cancer cell proliferationAuthors:Hoffmann Marta, Gogola Justyna, Ptak AnnaConference:New Insights in Rare Gynaecological Malignancies - ESGO State of the Art Conference 2018 (rok: 2018, ), Wydawca: BMJ JournalsData:konferencja 4-6 październikStatus:Published